NASDAQ:PYXS

Pyxis Oncology Stock Forecast

etoro logo Buy PYXS
*Your capital is at risk
$3.83
+0.100 (+2.68%)
At Close: Aug 10, 2026

Should you buy PYXS stock?

Last updated:

Based on market data through , StockInvest.us rates Pyxis Oncology, Inc. (PYXS) as a Strong Buy Candidate with a technical score of 5.85 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 88.67%
  • 3-month trend forecast Up 47.86%
  • Strong Buy Candidate 5.85
AI Analysis AI Analysis of PYXS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PYXS to Watchlist?
Some Reasons Why To Add PYXS:
  • +268.3% price growth over the last year
  • High gross margin of 99.8%
  • +233.0% YTD performance
PDF

Stronger technical forecast for Pyxis Oncology, Inc. stock price after Monday trading
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 18, 2026 Gain 88.67%

The Pyxis Oncology, Inc. stock price gained 2.68% on the last trading day (Monday, 10th Aug 2026), rising from $3.73 to $3.83. During the last trading day the stock fluctuated 7.12% from a day low at $3.72 to a day high of $3.99. The price has risen in 5 of the last 10 days and is up by 31.62% over the past 2 weeks. Volume fell on the last day by -222 thousand shares and in total, 997 thousand shares were bought and sold for approximately $3.82 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $4.07 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 47.86% during the next 3 months and, with a 90% probability hold a price between $4.04 and $6.01 at the end of this 3-month period.

PYXS Signals & Forecast

Mostly positive signals in the chart today. The Pyxis Oncology, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.33 and $2.72. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 26, 2026, and so far it has risen 134.97%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Pyxis Oncology, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.07 and $3.01. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pyxis Oncology, Inc. finds support just below today's level at $3.07. If this is broken, then the next support from accumulated volume will be at $3.01 and $2.91.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.265 between high and low, or 7.12%. For the last week, the stock has had daily average volatility of 10.18%.

The Pyxis Oncology, Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $3.72 (-2.82%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 84 and this increases the risk substantially. There is a buy signal from a pivot bottom found 52 days ago.)

Trading Expectations (PYXS) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Pyxis Oncology, Inc. to open at $3.85, and during the day (based on 14 day Average True Range), to move between $3.68 and $3.98, which gives a possible trading interval of +/-$0.297 (+/-8.07%) up or down from last closing price. If Pyxis Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 8.07% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $3.07, some $0.760 (19.84%) from the current price of $3.83, our system finds the risk reward attractive.

Earnings coming up

Pyxis Oncology, Inc. will release earnings BMO on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.350. We will update the financials statements for Pyxis Oncology, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 13.16% in the first trading day after earnings release.

Is Pyxis Oncology, Inc. stock A Buy?

Pyxis Oncology, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.849 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $3.85 ( 0.392%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PYXS Performance

Trading levels for PYXS

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.11 7.31%
R2 4.01 4.67%
R1 3.95 3.03%
Price 3.83
S1 3.74 -2.25%
S2 3.68 -3.88%
S3 3.58 -6.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 3.83
S1 3.07 -19.84%
S2 3.01 -21.41%
S3 2.91 -24.02%

FAQ

What is the symbol for Pyxis Oncology, Inc. Stock and on which exchange is it traded?
The symbol for Pyxis Oncology, Inc. is PYXS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pyxis Oncology, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Pyxis Oncology, Inc. (PYXS) as a Strong Buy Candidate with a technical score of 5.85 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation. Since the Buy signal began on Jun 18, 2026, the price has risen 88.67%. The current 3-month trend forecast projects a rise of 47.86%.

How to buy Pyxis Oncology, Inc. Stock?
Pyxis Oncology, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pyxis Oncology, Inc. Stock.

What's the current price of Pyxis Oncology, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Pyxis Oncology, Inc. (PYXS) share was $3.83.

What is the 52-week high and low for Pyxis Oncology, Inc. Stock?
The 52-week high for Pyxis Oncology, Inc. Stock is $5.55 and the 52-week low is $0.97.

What is the market capitalization of Pyxis Oncology, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Pyxis Oncology, Inc. is 242.651M.

When is the next earnings date for Pyxis Oncology, Inc.?
The upcoming earnings date for Pyxis Oncology, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT PYXIS ONCOLOGY, INC.
Pyxis Oncology
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therap...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE